The benefits of combination approaches in CTCL

Jan P. Nicolay, MD, Ruprecht Karls University of Heidelberg, Mannheim, Germany, talks on the use of combination approaches in the treatment of cutaneous T-cell lymphoma (CTCL), describing how the targeting of multiple pathways involved in cell death can prevent cells from bypassing apoptosis. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

• فئة